Ticagrelor: Uses, Side Effects, Storage and Precautions
Written by Medicover Team and Medically Reviewed by Dr P Sridhar, Cardiology
Ticagrelor tablet is a prescription antiplatelet (blood-thinning) medication primarily used to prevent blood clots in individuals at high risk of cardiovascular events. Marketed under the brand name Brilinta, this medicine is often used in combination with other drugs to reduce the chances of heart attacks, strokes, or complications following heart-related surgeries. Ticagrelor 90 mg is a commonly prescribed dosage that helps maintain blood flow and prevent clot formation. Always use the ticagrelor tablet as directed by your healthcare provider.
Ticagrelor tablet is a fast-acting blood thinner that works by preventing platelets in the blood from sticking together, which helps reduce the risk of dangerous clots. It is especially effective in patients who have had a heart attack, acute coronary syndrome (ACS), or are diagnosed with coronary artery disease (CAD).
Ticagrelor helps prevent blood clots, reducing the risk of heart attacks, strokes, and other complications in people with heart conditions like acute coronary syndrome (ACS) and coronary artery disease (CAD). Ticagrelor 90 mg uses include maintaining blood flow in patients after a heart procedure or stent placement. Ticagrelor tablet uses also extend to preventing future cardiovascular events in high-risk individuals. It must be taken under medical supervision to avoid bleeding risks and ensure proper heart health management.
Ticagrelor belongs to a class of drugs called P2Y12 platelet inhibitors. It blocks a receptor on platelets, making it harder for them to clump together. This reduces the risk of blood clots forming in arteries, which is critical in preventing heart attacks and strokes. The ticagrelor 90 mg tablet works by maintaining consistent platelet inhibition throughout the day. Doctors often prescribe it after certain heart procedures or in patients with acute coronary syndrome to help reduce further cardiovascular risks.
The recommended ticagrelor 90 mg dosage is typically one tablet taken twice daily, along with a low-dose aspirin, as directed by a healthcare provider. This regimen is commonly used for patients with acute coronary syndrome or those who have had a stent placed in their arteries. The ticagrelor tablet dosage may vary based on individual health conditions and treatment goals. It is important to follow the prescribed dosage exactly to reduce the risk of blood clots and related complications.
If you miss a dose of the ticagrelor tablet, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed one. Do not take two doses at once to make up for it. Missing doses can reduce the medicine's effectiveness in preventing blood clots. Always follow your doctor's instructions carefully and try to take ticagrelor at the same time each day to maintain consistent protection.
An overdose of the ticagrelor tablet may lead to excessive bleeding, including internal bleeding or prolonged bleeding from minor injuries. Symptoms like dizziness, shortness of breath, or vomiting blood may occur. In severe cases, urgent medical attention is required to manage bleeding risks. There is no specific antidote for a ticagrelor overdose, so supportive care is essential. If an overdose is suspected, seek emergency medical help immediately and do not attempt to treat it without professional supervision.
Symptoms may include:
Consult your healthcare provider before taking any medication. In case of a suspected overdose, seek emergency medical attention immediately.
Get a second opinion from trusted experts and makeconfident, informed decisions.
Get Second OpinionThe side effects of ticagrelor tablets may include shortness of breath, dizziness, and an increased risk of bleeding, such as nosebleeds or bruising easily. Some patients may also experience headaches, nausea, or diarrhea. Serious side effects of ticagrelor 90mg tablets can involve internal bleeding or irregular heartbeat. It is important to report any unusual symptoms to your doctor. Always follow medical advice and monitor for adverse reactions when taking ticagrelor as part of your treatment plan.
Ticagrelor should be avoided in patients with active bleeding or a history of brain hemorrhage. Caution is advised in liver disease, upcoming surgery, and during pregnancy or breastfeeding. Patients must inform their doctor about any existing medical conditions or medications before starting ticagrelor. Close monitoring may be required in certain cases to prevent complications. It is important to follow medical advice strictly and never adjust the dose or stop the medication without consulting a healthcare professional.
Ticagrelor is typically prescribed for adults only. It is not recommended for use in children. Clinical studies and safety data are limited for pediatric use, so healthcare providers avoid prescribing it to individuals under 18. The safety and effectiveness of ticagrelor in children have not been established. Always consult a doctor before using this medication, especially for younger patients, to ensure appropriate treatment and avoid unnecessary health risks.
Ticagrelor may interact with other blood thinners, NSAIDs, certain antibiotics, antifungals, and seizure medications, increasing the risk of side effects or reducing drug effectiveness.
Ticagrelor may interact with:
Always inform your doctor of any medications or supplements you are taking.
Ticagrelor tablets should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), away from direct sunlight, moisture, and heat. Keep the tablets in their original packaging and do not transfer them to other containers. Ensure the medicine is kept out of reach of children and pets. Do not use the tablets past their expiration date. Avoid storing in bathrooms or damp areas, as humidity can affect the tablet's effectiveness and stability.
Improper storage may reduce the medication's effectiveness. Always keep it in its original packaging and out of reach of children. Exposure to heat, moisture, or direct sunlight can cause the tablet to break down or lose potency over time. Avoid storing it in the bathroom or near a heat source. Storing ticagrelor properly ensures its safety and full therapeutic effect. Always check the label for storage instructions and expiration dates to maintain its quality.
| Ticagrelor | Clopidogrel |
|---|---|
| Belongs to a class of drugs known as antiplatelet agents. It works by stopping platelets from clumping together and causing a heart attack or stroke. | Belongs to a class of drugs known as antiplatelet agents. It works similarly to Ticagrelor by stopping platelets from clumping together. |
| Blood thinner and antiplatelet drug that increases blood flow and reduces the likelihood of a lethal blood clot. | Blood thinner used alone or with aspirin to avoid serious heart and blood vessel complications in people who have had a stroke, heart attack, or extreme chest pain. |
| Common side effects: Nausea, dizziness, bleeding more easily, increased uric acid. | Common side effects: Headache, dizziness, nausea, vomiting, stomach pain, diarrhea. |

Still have questions? Speak with our experts now!
040-68334455Ticagrelor is a blood thinner and antiplatelet drug. It increases the flow of blood into your veins, reducing the likelihood of potentially lethal blood clots.
Ticagrelor 90 mg functions as a blood thinner and antiplatelet drug, promoting increased blood flow and reducing the risk of developing dangerous blood clots.
Ticagrelor (Brilinta) is typically used for 6 to 12 months or longer after a stent placement or heart attack. It is prescribed alongside low-dose aspirin to prevent blood clot formation.
No, Ticagrelor is not an anticoagulant. It is an antiplatelet medication that inhibits platelet aggregation, reducing the risk of blood clot formation.
Common side effects of Ticagrelor include nausea, dizziness, increased susceptibility to bleeding, and elevated levels of uric acid in the body.
Ticagrelor is not an anticoagulant but an antiplatelet medication. It helps prevent blood clots by stopping platelets from sticking together, reducing the risk of heart attacks and strokes.
Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.